Jose C. Palacios

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Tumor-infiltrating lymphocytes differ across MammaPrint® classifications in breast cancer.

Tumor-infiltrating lymphocytes differ across MammaPrint® classifications in breast cancer.

Journal: Endocrine-related cancer
Published: March 03, 2026

Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.

Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.

Journal: The Lancet. Oncology
Published: January 19, 2026

Association of Body Mass Index with Tumor-Infiltrating Lymphocytes and Treatment Response in Early HER2-Positive Breast Cancer.

Association of Body Mass Index with Tumor-Infiltrating Lymphocytes and Treatment Response in Early HER2-Positive Breast Cancer.

Journal: International journal of women's health
Published: January 14, 2026

Implementation of a Multidisciplinary Protocol for the Safe Handling of Iodine-125 Radioactive Seeds in the Pathology Laboratory.

Implementation of a Multidisciplinary Protocol for the Safe Handling of Iodine-125 Radioactive Seeds in the Pathology Laboratory.

Journal: International journal of breast cancer
Published: December 24, 2025

Corrigendum to "HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study" [Gynecologic Oncology 194 (2025) 33-40].

Corrigendum to "HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study" [Gynecologic Oncology 194 (2025) 33-40].

Journal: Gynecologic oncology
Published: November 09, 2025

MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma.

MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 30, 2025

Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma.

Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma.

Journal: Endocrine pathology
Published: October 10, 2025

Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification.

Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification.

Journal: The Journal of pathology
Published: June 24, 2025

Percutaneous ultrasound-guided repair of Achilles tendon rupture: a cadaveric study and preliminary clinical report.

Percutaneous ultrasound-guided repair of Achilles tendon rupture: a cadaveric study and preliminary clinical report.

Journal: Journal of orthopaedic surgery and research
Published: April 27, 2025

Ipsilateral Breast Carcinoma Recurrence: True Recurrence or New Primary? A Clinicopathologic and Molecular Study.

Ipsilateral Breast Carcinoma Recurrence: True Recurrence or New Primary? A Clinicopathologic and Molecular Study.

Journal: The American journal of surgical pathology
Published: January 09, 2025

Single-Cell RNA Sequencing on Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Identified Multi-Ciliary Cells in Breast Cancer.

Single-Cell RNA Sequencing on Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Identified Multi-Ciliary Cells in Breast Cancer.

Journal: Cells
Published: December 23, 2024

HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study.

HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study.

Journal: Gynecologic oncology
Published: November 06, 2024
Showing 1-12 of 107

Last Updated: 09/26/2026